FrancophonIA/ELRC3.0 huggingface dataset:
English: Suggested measures include induction of emesis if ingestion is recent, and correction of dehydration, electrolyte imbalance, hepatic coma and hypotension by established procedures.
Danish: Korrektion af væske- og elektrolytbalance, hepatisk koma og hypotension behandles henhold til gældende procedurer.
English: Common: Hyperkalaemia, mild reduction of haematocrit and haemoglobin Uncommon: Mild increase in urea and creatinine serum levels Very rare: Increase in hepatic enzymes and bilirubin.
Danish: Ikke almindelig: Lille stigning i urinstof og serumkreatininkoncentration.
English: NAME OF THE MEDICINAL PRODUCT Cozaar Comp 50 mg/12.5 mg Losartan and hydrochlorothiazide
Danish: LÆGEMIDLETS NAVN Cozaar Comp. 50 mg/12,5 mg Losartan og hydrochlorthiazid
English: HYZAAR (Losartan/Hydrochlorothia zide)
Danish: HYZAAR (Losartan/Hydrochlorthiazide)
English: Light yellow, oval film-coated tablets marked 747 on one side and plain on the other.
Danish: Cozaar Comp. 100 mg/25 mg Lysegule, ovale filmovertrukne tabletter mærket 747 på den ene side og glatte på den anden side.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 50 mg losartan potassium and 12.5 mg hydrochlorothiazide.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder 50 mg losartan og 12,5 mg hydrochlorthiazid.
English: Cozaar Comp 100 mg/12.5 mg mg contains 8.48 mg (0.216 mEq) of potassium.
Danish: Cozaar Comp. 100 mg/12,5 mg indeholder 8,48 mg (0,216 mEq) kalium.
English: NAME OF THE MEDICINAL PRODUCT Cozaar Comp 100 mg/12.5 mg Losartan and hydrochlorothiazide
Danish: LÆGEMIDLETS NAVN Cozaar Comp. 100 mg/12,5 mg Losartan og hydrochlorthiazid
English: Cozaar Comp 100 mg/12.5 mg mg is supplied as unscored film-coated tablets.
Danish: Cozaar Comp. 100 mg/12,5 mg fås som filmovertrukne tabletter uden delekærv.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer carton for Cozaar Comp 100 mg/25 mg film-coated tablets blister
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Ydre karton for Cozaar Comp. 100 mg/25 mg filmovertrukne tabletter - blister
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 100 mg losartan potassium and 12.5 mg hydrochlorothiazide.
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver tablet indeholder 100 mg losartan og 12,5 mg hydrochlorthiazid.
English: NAME OF THE MEDICINAL PRODUCT Cozaar Comp 100 mg/25 mg mg film-coated tablets Losartan and hydrochlorothiazide
Danish: Cozaar Comp. 100 mg/25 mg filmovertrukne tabletter Losartan og hydrochlorthiazid
English: Musculoskeletal and connective tissue disorders Uncommon: Muscle cramps
Danish: Knogler, led, muskler og bindevæv Ikke almindelig: Muskelkramper.
English: Norway MSD BV Waarderweg 39
Danish: MSD BV Waarderweg 39 2031 BN Haarlem Holland
English: Common: Cough, upper respiratory infection, nasal congestion, sinusitis, sinus disorder Uncommon: Pharyngeal discomfort, pharyngitis, laryngitis, dyspnoea, bronchitis, epistaxis, rhinitis, respiratory congestion
Danish: Ikke almindelig: Gener i svælget, pharyngitis, laryngitis, dyspnø, bronkitis, epistaksis, rhinitis, respiratorisk kongestion.
English: Cozaar Comp 50 mg/12.5 mg - PVC/PE/PVDC blister packages with aluminum foil lidding in packs of 4, 7, 10, 14, 20, 28, 30, 50, 56, 84, 98, or 280 tablets.
Danish: Cozaar Comp. 50 mg/12,5 mg - PVC/PE/PVDC blisterpakninger med aluminiumsfolie i pakninger à 4, 7, 10, 14, 20, 28, 30, 50, 56, 84, 98 eller 280 tabletter.
English: NAME OF THE MEDICINAL PRODUCT Cozaar Comp 50 mg/12.5 mg mg film-coated tablets Losartan and hydrochlorothiazide
Danish: Cozaar Comp. 50 mg/12,5 mg filmovertrukne tabletter Losartan og hydrochlorthiazid
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer carton for Cozaar Comp 50 mg/12.5 mg film-coated tablets blister
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Ydre karton for Cozaar Comp. 50 mg/12,5 mg filmovertrukne tabletter - blister
English: Merck Sharp & Dohme Italia S.p.A. via G Fabbroni 6 , 00191 Rome Italy
Danish: Via G. Fabbroni 6, 00191 Rom, Italien
English: Cozaar Comp 100 mg/12.5 mg - PVC/PE/PVDC blister packages with aluminum foil lidding in packs of 14, 15, 28, 30, 50, 56, 84, 90, 98, 280 tablets.
Danish: Cozaar Comp. 100 mg/12,5 mg - PVC/PE/PVDC blisterpakninger med aluminiumsfolie i pakninger à 14, 15, 28, 30, 50, 56, 84, 90, 98, 280 tabletter.
English: Marketing Authorisation Holder Invented name
Danish: Medlemsstat Indehaver af markedsføringstilladelse
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer carton for Cozaar Comp 100 mg/12.5 mg film-coated tablets blister
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Ydre karton for Cozaar Comp. 100 mg/12,5 mg filmovertrukne tabletter - blister
English: What Cozaar Comp looks like and contents of the pack Cozaar Comp 50 mg/12.5 mg is supplied as scored or unscored film-coated tablets.
Danish: Cozaar Comp. 50 mg/12,5 mg fås som filmovertrukne tabletter med eller uden delekærv.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer carton for Cozaar Comp 100 mg/25 mg film-coated tablets HDPE bottle
Danish: MINDSTEKRAV TIL MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Ydre karton for Cozaar Comp. 100 mg/25 mg filmovertrukne tabletter - HDPE-beholder
English: Cozaar Comp 100 mg/25 mg - PVC/PE/PVDC blister packages with aluminum foil lidding in packs of 7, 14, 28, 30, 50, 56, 84, 90, 98, or 280 tablets.
Danish: Cozaar Comp. 100 mg/25 mg - PVC/PE/PVDC blisterpakninger med aluminiumsfolie i pakninger à 7, 14, 28, 30, 50, 56, 84, 90, 98 eller 280 tabletter.
English: NAME OF THE MEDICINAL PRODUCT Cozaar Comp 100 mg/12.5 mg mg film-coated tablets Losartan and hydrochlorothiazide
Danish: Cozaar Comp. 100 mg/12,5 mg filmovertrukne tabletter Losartan og hydrochlorthiazid
English: HOW TO TAKE COZAAR COMP
Danish: Sådan skal De tage Cozaar Comp.
English: BEFORE YOU TAKE COZAAR COMP
Danish: DET SKAL DE VIDE, FØR DE BEGYNDER AT TAGE COZAAR COMP.
English: NAME OF THE MEDICINAL PRODUCT Cozaar Comp and associated names (see Annex I) 50 mg/12.5 mg film-coated tablets Cozaar Comp and associated names (see Annex I) 100 mg/12.5 mg film-coated tablets Cozaar Comp and associated names (see Annex I) 100 mg/25 mg film-coated tablets [To be implemented nationally]
Danish: Cozaar Comp. og tilhørende navne (se bilag I) 100 mg/12,5 mg filmovertrukne tabletter.
English: Therefore Cozaar Comp is contraindicated in patients with severe hepatic impairment (see sections 4.2, 4.3 and 5.2).
Danish: Derfor bør Cozaar Comp. ikke gives til patienter med svær leverinsufficiens (se pkt.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer carton for Cozaar Comp 50 mg/12.5 mg film-coated tablets HDPE Bottle
Danish: MINDSTEKRAV TIL MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Ydre karton for Cozaar Comp. 50 mg/12,5 mg filmovertrukne tabletter - HDPE-beholder
English: Anaphylactic reactions, angioedema, urticaria
Danish: Immunsystemet Sjælden: Anafylaktiske reaktioner, angioødem, urticaria.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer carton for Cozaar Comp 100 mg/12.5 mg film-coated tablets HDPE bottle
Danish: MINDSTEKRAV TIL MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Ydre karton for Cozaar Comp. 100 mg/12,5 mg filmovertrukne tabletter - HDPE-beholder
English: What Cozaar Comp is and what it is used for Before you take Cozaar Comp How to take Cozaar Comp Possible side effects
Danish: Cozaar Comp.'s virkning og hvad De skal bruge det til 2.
English: HOW TO STORE COZAAR COMP
Danish: SÅDAN OPBEVARER DE COZAAR COMP.
English: and elicits several important biological actions, including vasoconstriction and the release of aldosterone.Angiotensin II also stimulates smooth-muscle cell proliferation.
Danish: Angiotensin-II stimulerer også formeringen af celler i den glatte muskulatur.
English: If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.
Danish: Tal med lægen eller apoteket, hvis en bivirkning bliver værre, eller De får bivirkninger, som ikke er nævnt her.
English: • This medicine has been prescribed for you.
Danish: • Lægen har ordineret Cozaar Comp. til Dem personligt.
English: Annex III Amendments to relevant sections of the summaries of product characteristics and package leaflets
Danish: Bilag III Ændringer til relevante afsnit i produktresumeer og indlægssedler
English: • Acute retinopathies of vascular origin
Danish: • Akutte retinopatier af vaskulær oprindelse
English: • Symptomatic treatment of chronic pathological cognitive and neurosensorial impairment in elderly (excluding Alzheimer's disease and other dementia)
Danish: • Symptomatisk behandling af kroniske, patologiske, kognitive og neurosensoriske svækkelser hos ældre (ekskl.
English: • Ancillary treatment of visual acuity decrease and visual field disturbances presumably of vascular origin
Danish: • Supplerende behandling af synsnedsættelse og synsfeltforstyrrelser, formentlig af vaskulær oprindelse
English: All references to the above mentioned indications should be deleted from the remaining relevant sections of the summaries of product characteristics.
Danish: Alle henvisninger til ovennævnte indikationer skal slettes i de øvrige afsnit i produktresuméerne.
English: The medicine has an acceptable safety profile.
Danish: Lægemidlet har en acceptabel sikkerhedsprofil.
English: Intrarosa prasterone
Danish: Intrarosa prasteron
English: In both studies, 6.5 mg Intrarosa was given once a day for 12 weeks.
Danish: I begge undersøgelser blev 6,5 mg Intrarosa givet én gang dagligt i 12 uger.
English: The full EPAR for Intrarosa can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Intrarosa findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This is a summary of the European public assessment report (EPAR) for Intrarosa.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Intrarosa.
English: Other information about Intrarosa
Danish: Andre oplysninger om Intrarosa
English: The company that markets Intrarosa is required to conduct a study on how the medicine is used in clinical practice, including whether it is used according to the authorised product information.
Danish: Virksomheden, der markedsfører Intrarosa, skal gennemføre en undersøgelse af, hvordan lægemidlet anvendes i klinisk praksis, herunder om det anvendes i overensstemmelse med den godkendte produktinformation.
English: Intrarosa must not be used in patients with the following conditions: genital bleeding where the cause has not been diagnosed, known or suspected breast cancer or oestrogen-dependent cancer, previous breast cancer, untreated endometrial hyperplasia (thickening of the lining of the womb), acute (shortterm) liver disease, previous liver disease where liver function tests are still abnormal, previous or current venous thromboembolism (formation of blood clots in the veins), thrombophilic disorders (abnormal blood clotting), active or recent arterial thromboembolic disease (disease caused by blood clots in the arteries), porphyria (inability to break down chemicals called porphyrins).
Danish: Intrarosa må ikke anvendes hos patienter med følgende sygdomme: blødning i skeden (hvor årsagen ikke er klarlagt), diagnosticeret brystkræft eller mistanke derom eller østrogen-afhængig kræft, tidligere brystkræft, ubehandlet endometriehyperplasi (fortykkelse af slimhinden i livmoderen), akut leversygdom, tidligere leversygdom (hvor leverfunktionstallene stadig ikke er normale), tidligere eller aktuel venøs tromboemboli (dannelse af blodpropper i venerne), trombofile sygdomme (unormal blodstørkning), aktiv eller nylig arteriel tromboemboli (dannelse af blodpropper i arterierne), porfyri (manglende evne til at nedbryde et kemisk stof, der hedder porfyriner).
English: What measures are being taken to ensure the safe and effective use of Intrarosa?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Intrarosa?
English: Pain during sexual intercourse was self-assessed by patients using a standard scale ranging from 0 (no pain) to 3 (severe pain).
Danish: Smerter under samleje blev vurderet af patienterne selv ved hjælp af en standardskala fra 0 (ingen smerter) til 3 (kraftige smerter).
English: Why is Intrarosa approved?
Danish: Hvorfor blev Intrarosa godkendt?
English: The European Medicines Agency therefore considered that Intrarosa's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Det Europæiske lægemiddelagentur konkluderede derfor, at fordelene ved Intrarosa opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: What is Intrarosa and what is it used for?
Danish: Hvad er Intrarosa, og hvad anvendes det til?
English: The most common side effect with Intrarosa (which may affect up to 1 in 10 people) is vaginal discharge.
Danish: Den mest almindelige bivirkning ved Intrarosa (som kan forekomme hos op til 1 ud af 10 personer) er vaginalt udflåd.
English: Intrarosa is available as a 6.5 mg pessary.
Danish: Intrarosa fås som en 6,5 mg-stikpille.
English: Intrarosa contains the active substance prasterone, also known as dehydroepiandrosterone (DHEA).
Danish: Intrarosa indeholder det aktive stof prasteron (også kendt som dehydroepiandrosteron).
English: The effect seen in the placebo group was explained by the lubricant effect of the excipient.
Danish: Virkningen i placebo-gruppen blev forklaret med hjælpestoffets smørende virkning.
English: It is not intended to provide practical advice on how to use Intrarosa.
Danish: Det er ikke en praktisk vejledning i, hvordan Intrarosa bør anvendes.
English: For more information about treatment with Intrarosa, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Intrarosa, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: The pain reduced by 1.3 and 1.4 points with Intrarosa compared with 0.9 and 1.1 points with placebo.
Danish: Smerterne faldt med 1,3 og 1,4 point med Intrarosa sammenholdt med 0,9 og 1,1 point med placebo.
English: Patients taking Intrarosa had a modest reduction in pain during sexual intercourse, which was similar or better to the effect seen in patients taking placebo.
Danish: Patienter, der tog Intrarosa, oplevede en moderat reduktion af smerter under samleje, hvilket er det samme som eller bedre end den virkning, som patienter på placebo oplevede.
English: What are the risks associated with Intrarosa?
Danish: Hvilke risici er der forbundet med Intrarosa?
English: Two studies involving 813 post-menopausal women with vulvar and vaginal atrophy found that treatment with Intrarosa was more effective than placebo (a dummy treatment) at reducing signs of thinning (atrophy) of vaginal tissues.
Danish: Det er i to undersøgelser af 813 postmenopausale kvinder med vulvær og vaginal atrofi påvist, at behandling med Intrarosa er mere effektivt end placebo (ikke-aktivt stof) til at reducere tegn på tyndere væv i skeden (atrofi).
English: Women should insert the pessary into their vagina, once daily, at bedtime.
Danish: Kvinden bør indføre stikpillen i skeden én gang dagligt ved sengetid.
English: In women with vulvar and vaginal atrophy, the wall of the vagina and surrounding tissues become thinner and can cause symptoms such as dryness, irritation and soreness around the genital area, and painful sexual intercourse.
Danish: Hos kvinder med vulvær og vaginal atrofi bliver skedevæggen og de omkringliggende væv tyndere og kan forårsage symptomer som f.eks. tørhed, irritation og ømhed i skeden samt smerter ved samleje.
English: The active substance of Intrarosa, prasterone, is converted into the sex hormones oestrogens and androgens when inserted into the vagina.
Danish: Det aktive stof i Intrarosa, prasteron, omdannes til kønshormonerne østrogen og androgen, når stikpillen indføres i skeden.
English: As a result of increasing oestrogen levels, the number of superficial cells in the tissues in and around the vagina increases thus relieving the symptoms of vaginal atrophy.
Danish: Som følge af stigningen i østrogen-niveauet stiger antallet af overfladeceller i vævene i og omkring skeden og dermed lindres symptomerne på vaginal atrofi.
English: Intrarosa has been shown to improve the structure of the vaginal tissues and to have a modest effect on pain during sexual intercourse.
Danish: Det er påvist, at Intrarosa forbedrer strukturen i vævene i skeden, og at det har en besked virkning på smerter under samleje.
English: For practical information about using Intrarosa, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Intrarosa, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: There was also a decrease in the number of parabasal cells (which normally increase with atrophy) of 42% and 47% with Intrarosa compared with 2% and 12% with placebo.
Danish: Der sås også et fald i antallet af parabasale celler (der normalt stiger ved atrofi) på 42 % og 47 % ved behandling med Intrarosa sammenholdt med ca. 2 % og 12 % ved behandling med placebo.
English: For the full list of side effects reported with Intrarosa, see the package leaflet.
Danish: Den fuldstændige liste over indberettede bivirkninger ved Intrarosa fremgår af indlægssedlen.
English: How is Intrarosa used?
Danish: Hvordan anvendes Intrarosa?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Intrarosa have also been included in the summary of product characteristics and the package leaflet.
Danish: Der er desuden anført anbefalinger og forholdsregler i produktresuméet og indlægssedlen, som patienter og sundhedspersonale skal følge for at sikre risikofri og effektiv anvendelse af Intrarosa.
English: What benefits of Intrarosa have been shown in studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Intrarosa?
English: Results showed that the number of superficial cells (which normally falls with atrophy) increased by 6% and 10% with Intrarosa compared with about 1% and 2% with placebo.
Danish: Resultaterne viste, at antallet af overfladeceller (der normalt falder ved atrofi) steg med 6 % og 10 % ved behandling med Intrarosa sammenholdt med ca. 1 % og 2 % ved behandling med placebo.
English: Intrarosa is a medicine used to treat postmenopausal women with moderate to severe symptoms of vulvar and vaginal atrophy.
Danish: Intrarosa er et lægemiddel til behandling af kvinder efter overgangsalderen med moderate til svære symptomer på såkaldt vulvær og vaginal atrofi, dvs. tørre og irritable slimhinder i skeden.
English: In addition, Intrarosa treatment was better at increasing acidity in the vagina (which normally becomes less acidic with atrophy), with pH values reducing by 0.9 and 1.0 with Intrarosa and by 0.2 and 0.3 with placebo.
Danish: Desuden var behandling med Intrarosa mere effektivt til at øge surheden i skeden (der normalt bliver mindre sur ved atrofi), idet pH-værdierne faldt med 0,9 og 1,0 ved behandling med Intrarosa sammenholdt med 0,2 og 0,3 ved behandling med placebo.
English: In women who have been through the menopause, the thinning of the tissues in and around the vagina is caused by a fall in levels of the sex hormone oestrogen.
Danish: Hos kvinder, der har været gennem overgangsalderen, skyldes det tyndere væv i og omkring skeden et fald i niveauet af kønshormonet østrogen.
English: How does Intrarosa work?
Danish: Hvordan virker Intrarosa?
English: This did not affect long-term development of colonies.
Danish: Dette påvirkede ikke den langsigtede udvikling af kolonierne.
English: The dispersion should be warmed to 30-35˚C before application.
Danish: Dispersionen skal opvarmes til 30-35 ˚C før anvendelse.
English: Contaminated clothing should be removed immediately.
Danish: Forurenet tøj skal øjeblikkeligt tages af.
English: Contact with these areas should be avoided, both directly and by hand-to-mouth or hand-to-eye contact.
Danish: Kontakt med disse områder bør undgås, både direkte og via hånd til mund- eller hånd til øje-kontakt.
English: The effectiveness of Oxybee to kill mites was 97% and 95% in these studies.
Danish: Oxybees virkning med hensyn til at slå mider ihjel var henholdsvis 97 % og 95 % i disse undersøgelser.
English: People must not eat, drink or smoke while using the medicine.
Danish: Der må ikke spises, drikkes eller ryges, mens lægemidlet håndteres.
English: The full EPAR for Oxybee can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Oxybee findes på agenturets websted under: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: In case of eye contact, the affected eye should be rinsed thoroughly with water (contact lenses should be removed first).
Danish: I tilfælde af øjenkontakt skal det berørte øje skylles grundigt med vand (kontaktlinser fjernes først).
English: This is a summary of the European public assessment report (EPAR) for Oxybee.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Oxybee.
English: The withdrawal period for honey from honey bees treated with Oxybee is ‘zero' days, which means there is no mandatory waiting time.
Danish: Tilbageholdelsestiden for honning fra honningbier, der behandles med Oxybee, er "nul" dage, hvilket vil sige, at der ikke er nogen påkrævet ventetid.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Oxybee's benefits are greater than its risks and recommended that it be approved for use in the EU.
Danish: Agenturets Udvalg for Lægemidler til Dyr (CVMP) konkluderede, at fordelene ved Oxybee opvejer risiciene, og anbefalede, at det godkendes til anvendelse i EU.
English: Dead mites were counted daily in the first study and three times per week in the second study for three weeks post treatment.
Danish: I den første undersøgelse blev de døde mider optalt dagligt efter behandlingen i tre uger, mens de blev optalt tre gange om ugen i den anden undersøgelse.
English: In the first study treatment with Oxybee was compared to another oxalic acid medicine and to a group with no treatment whilst in the second study treatment with Oxybee was compared to a group with no treatment.
Danish: I den første undersøgelse blev behandling med Oxybee sammenlignet med behandling med et andet oxalsyreholdigt lægemiddel og med en gruppe, der ikke fik nogen behandling, mens behandling med Oxybee i den anden undersøgelse blev sammenlignet med en gruppe, der ikke blev behandlet.
English: The most common side effect with Oxybee (which may affect more than 1 in 10 bee colonies) is an increased number of bee deaths.
Danish: Den hyppigste bivirkning ved Oxybee (som kan optræde hos mere end 1 ud af 10 bikolonier) er øget dødelighed blandt bierne.
English: Protective clothing, acid resistant gloves and safety glasses should be worn during treatment.
Danish: Der bør anvendes beskyttelsesdragt, syrefaste handsker og sikkerhedsbriller under behandlingen.
English: A significant mite infestation can lead to the collapse of a honey bee colony.
Danish: Et stort mideangreb kan medføre en honningbikolonis kollaps.
English: Hands and exposed skin should be washed with soap and plenty of water immediately.
Danish: Hænder og udsat hud vaskes straks med sæbe og rigeligt vand.
English: Oxybee is trickled onto bees in the hive and should only be used when the temperature outside the hives is at least 3˚C.
Danish: Oxybee dryppes på bierne i bistadet og bør kun anvendes, når temperaturen uden for bistadet er mindst 3 ˚C.
English: Medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Danish: Der skal straks søges lægehjælp, og indlægssedlen eller etiketten skal vises til lægen.
English: Oxybee contains the active substance oxalic acid.
Danish: Oxybee indeholder det aktive stof oxalsyre.